Lantheus Holdings Inc (FRA:0L8)
€ 72.84 -1.36 (-1.83%) Market Cap: 5.28 Bil Enterprise Value: 5.19 Bil PE Ratio: 12.16 PB Ratio: 5.84 GF Score: 80/100

Lantheus Holdings Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 01:50PM GMT
Release Date Price: €26.2 (-0.76%)
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

Great. Thanks so much. So welcome, everybody, and good morning. Thanks for joining us this morning for Lantheus. My name is Matt Miksic. I cover medical devices here at Credit Suisse, and we're very pleased to have with us the team from Lantheus. Mary Anne Heino, President and CEO; Bob Marshall, CFO; and Mark Kinarney, Senior Director of Investor Relations.

So team, thanks so much for joining us this year. I'm going to pass it over to you to run through a slide deck and a presentation and time for meeting at the end, we'll go through a couple of questions.

Mary Anne Heino
Lantheus Holdings, Inc. - CEO, President & Director

Thank you, Matt. Good morning, everyone. It's great to be here. I'm Mary Heino, President and CEO of Lantheus, and I'm pleased to have this time to share with you some thoughts about where we are where we're taking this company. So Mark, if you move forward, I will share the necessary safe harbor statement slide.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot